Health Discovery Corporation (OTCBB: HDVY), a molecular diagnostics company that uses patent protected advanced mathematical techniques for personalized medicine, announces its Safe Health App Suite for the rapidly growing smart phone and tablet markets, leading with iPhone and Android mobile users. The Safe Health Apps, designed to increase awareness of and aid in self-assessment of important health issues, are expected to begin releasing as early as Q3. This announcement is on the heels of the company’s successful global release of MelApp, an app that promotes early detection against the world’s fastest growing cancer, Melanoma. “The early global adoption of MelApp illustrates the point that consumers desperately want tools to empower them to take an active role in managing their health,” explains Stephen D. Barnhill, M.D., Chairman and CEO of Health Discovery Corporation. “We are incredibly optimistic about our ability to package up segments of our patented technology into powerful, dynamic mobile applications that are redefining our culture, nationally and globally.” “App to Office”: Early Detection, Self Assessment Coupled with Medical Professionals The Safe Health App Suite is designed to provide information and encourage early detection across multiple health issues. Health Discovery Corporation believes that a comprehensive diagnosis and treatment is best provided by board certified physicians. As a reciprocal business strategy that creates an additional revenue channel for Health Discovery Corporation as well as a referral-based channel for physicians, each Safe Health app will leverage GPS technology to identify an opt-in physician referral network that matches app users with health care providers in their area. Herbert A Fritshe, Ph.D., Chief Science Officer for Health Discovery Corp. and retired Professor of Laboratory Medicine at MD Anderson Cancer Center, states, "We are creating more than just a suite of mobile applications that encourage consumers to participate in their self-health awareness. We are offering the physician community a simple and affordable referral-based model that can drive substantial traffic into their offices in what we call an ‘app to office’ platform.”
About Health Discovery CorporationHealth Discovery Corporation is a molecular diagnostics company that uses advanced mathematical techniques to analyze large amounts of data to uncover patterns that might otherwise be undetectable. It operates primarily in the emerging field of personalized medicine where such tools are critical to scientific discovery. Its primary business consists of licensing its intellectual property and developing its own product line of biomarker-based diagnostic tests that include human genes and genetic variations, as well as gene, protein, and metabolic expression differences and image analysis in digital pathology and radiology. For more information, see www.healthdiscoverycorp.com or www.melapp.net. For real-time updates follow the company on Facebook: http://www.facebook.com/MelApp and Twitter: http://twitter.com/SafeHealthApps. Forward-Looking Statements This document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, the accuracy of which is necessarily subject to risks and uncertainties, including, without limitation, statements regarding future performance, opportunities and investments, and anticipated results in general. From time to time the Company may make other forward-looking statements in relation to other matters, including without limitation, commercialization plans and strategic partnerships. Actual results may differ materially due to a variety of factors, including, among other things, the acceptance of our approach to applying mathematics, computer science and physics into the disciplines of biology, organic chemistry and medicine and our products and technologies associated with those approaches, the ability to develop and commercialize new drugs, therapies or other products based on our approaches, and other factors set forth from time to time in the Company’s Securities and Exchange Commission filings. All forward-looking statements and cautionary statements included in this document are made as of the date hereof based on information available to the Company as of the date hereof, and the Company assumes no obligation to update any forward-looking statement or cautionary statement.